Rene Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2016PTC274524. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 27 professional, Its leadership includes Narendra Parshuram Shelar (Managing Director), Nalamati Arun (Director). Past directors included Ammanna Nalamati, Madanmohan Fatehbir Bahadur, Nalamati Arun. It holds ₹2.32 Cr open charges and ₹3.30 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 206 Dimple Arcade Extension Building 10 Asha Nagar, Kandivali East, Mumbai, Maharashtra, 400101.
U51101MH2016PTC274524
274524
17 March 2016
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rene Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendra Parshuram Shelar | Managing Director | 17 Mar 2016 | Current |
| Nalamati Arun | Director | 23 Aug 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Aug 2016 | Past |
| Pramod Abcsdd | Director | 25 Aug 2016 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rene Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.29% decrease. The company also saw a substantial fall in profitability, with a 19.2% decrease in profit. The company's net worth Soared by an impressive increase of 17.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Rene Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹23,162,884.00
₹33,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 2024 | Axis Bank Limited | ₹2.00 Cr | Open |
| 21 Oct 2023 | Hdfc Bank Limited | ₹3.16 M | Open |
| 25 Jan 2022 | Axis Bank Limited | ₹1.65 Cr | Satisfied |
| 21 Jan 2022 | Axis Bank Limited | ₹1.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Rene Pharmaceuticals has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rene Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rene Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rene Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Rene Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 20.00 M with Charge ID 100870174 was registered on 05 Jan 2024. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 3.16 M with Charge ID 100856719 was registered on 21 Oct 2023. was recorded as a recent event.
A charge registered on 25 Jan 2022 via Charge ID 100547754 with Axis Bank Limited was fully satisfied on 01 Feb 2023. was recorded as a recent event.
Progress on A charge registered on 21 Jan 2022 via Charge ID 100547755 with Axis Bank Limited was fully satisfied on 01 Feb 2023. was documented.
The CIN of Rene Pharmaceuticals Private Limited is U51101MH2016PTC274524.
Rene Pharmaceuticals Private Limited is headquartered at 206 Dimple Arcade Extension Building 10 Asha Nagar, Kandivali East, Mumbai, Maharashtra, 400101.
Rene Pharmaceuticals Private Limited was incorporated on 17 March 2016.
The current directors of Rene Pharmaceuticals Private Limited are
The primary industry of Rene Pharmaceuticals Private Limited is Trade.
Rene Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rene Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Rene Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX